Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 3546 entries
View as:

The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis

Phase: N/A Priority: Normal
NCT ID: NCT00861809 Org: User:
Start: 06/30/09 End: 11/30/10 Due: 11/30/11

Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain.

Phase: N/A Priority: Normal
NCT ID: NCT02838407 Org: User:
Start: 09/23/13 End: 09/23/15 Due: 09/23/16

Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00350727 Org: User:
Start: 12/31/06 End: 12/31/09 Due: 12/31/10

SB-480848 In Subjects With Coronary Heart Disease

Phase: N/A Priority: Normal
NCT ID: NCT00269048 Org: User:
Start: 11/30/05 End: 09/30/06 Due: 09/30/07

Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00436007 Org: User:
Start: 04/30/07 End: 10/07/09 Due: 10/07/10

Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02483975 Org: User:
Start: 10/09/15 End: 06/21/16 Due: 06/21/17

A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00404274 Org: User:
Start: 11/01/06 End: 03/18/07 Due: 03/18/08

Pharmacokinetic Profile of Four Formulations of Fluticasone Furoate (FF) Using Unit Dose Dry Powder Inhaler (UD-DPI) Compared With FF ELLIPTA® Presentation

Phase: N/A Priority: Normal
NCT ID: NCT02218723 Org: User:
Start: 10/28/14 End: 12/19/14 Due: 12/19/15

A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02671188 Org: User:
Start: 06/01/18 End: 08/09/19 Due: 08/09/20

Anti-MAG First Administration to Human

Phase: N/A Priority: Normal
NCT ID: NCT00622609 Org: User:
Start: 08/01/07 End: 04/09/09 Due: 04/09/10

ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST)

Phase: N/A Priority: Normal
NCT ID: NCT00041509 Org: User:
Start: 01/31/02 End: 05/31/03 Due: 05/31/04

A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays

Phase: N/A Priority: Normal
NCT ID: NCT01098006 Org: User:
Start: 04/29/10 End: 02/20/12 Due: 02/20/13

Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00439959 Org: User:
Start: 10/31/06 End: 03/31/07 Due: 03/31/08

A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00612118 Org: User:
Start: 02/29/08 End: 05/31/08 Due: 05/31/09

Study to Evaluate Darapladib in Moderately Hepatically Impaired Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01154114 Org: User:
Start: 07/01/10 End: 10/15/10 Due: 10/15/11

Effect of Paracetamol on the Common Cold

Phase: N/A Priority: Normal
NCT ID: NCT01277081 Org: User:
Start: 10/31/10 End: 12/31/10 Due: 12/31/11

Bioequivalence Study for Mejoral 500 Product

Phase: N/A Priority: Normal
NCT ID: NCT02504775 Org: User:
Start: 08/01/15 End: 08/19/15 Due: 08/19/16

A Study to Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children

Phase: N/A Priority: Normal
NCT ID: NCT01379937 Org: User:
Start: 07/28/11 End: 10/05/12 Due: 10/05/13

A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02289495 Org: User:
Start: 11/18/14 End: 06/27/15 Due: 06/27/16

Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00985673 Org: User:
Start: 10/01/09 End: 12/29/10 Due: 12/29/11

Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT04581824 Org: User:
Start: 11/19/20 End: 09/10/24 Due: 09/10/25

Study Of Asthma In Patients Of African Descent

Phase: N/A Priority: Normal
NCT ID: NCT00102765 Org: User:
Start: 11/30/04 End: 04/30/07 Due: 04/30/08

An Evaluation Of BW430C (Lamotrigine) Versus Placebo In The Prevention Of Mood Episodes In Bipolar I Disorder Patients

Phase: N/A Priority: Normal
NCT ID: NCT00550407 Org: User:
Start: 11/30/07 End: 10/31/09 Due: 10/31/10

Special Drug Use Investigation for AMERGE® Tablet (Long-term)

Phase: N/A Priority: Normal
NCT ID: NCT01332383 Org: User:
Start: 05/31/09 End: 10/31/13 Due: 10/31/14

Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka

Phase: N/A Priority: Normal
NCT ID: NCT01803425 Org: User:
Start: 04/30/13 End: 04/30/14 Due: 04/30/15